{"id":293,"date":"2020-11-16T11:49:54","date_gmt":"2020-11-16T11:49:54","guid":{"rendered":"https:\/\/www.snijderlab.org\/news\/?p=293"},"modified":"2020-11-16T11:49:54","modified_gmt":"2020-11-16T11:49:54","slug":"pharmacoscopy-trial-presented-at-ash2020","status":"publish","type":"post","link":"https:\/\/www.snijderlab.org\/news\/2020\/11\/16\/pharmacoscopy-trial-presented-at-ash2020\/","title":{"rendered":"Pharmacoscopy trial presented at ASH2020"},"content":{"rendered":"\n<div class=\"wp-block-image\"><figure class=\"alignright size-large is-resized\"><a href=\"hematology.org\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/5\/5a\/American_Society_of_Hematology_logo.svg\" alt=\"\" width=\"162\" height=\"163\"\/><\/a><\/figure><\/div>\n\n\n\n<p>The final analysis of the succesful <a rel=\"noreferrer noopener\" href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03096821\" data-type=\"URL\" data-id=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03096821\" target=\"_blank\">EXALT-1 interventional trial<\/a> will be presented at the <a href=\"https:\/\/www.hematology.org\/meetings\/annual-meeting\">62nd annual meeting of the American Society for Hematology<\/a> by <a rel=\"noreferrer noopener\" href=\"https:\/\/innere-med-1.meduniwien.ac.at\/haematology\/functional-precision-hematology-group\/\" data-type=\"URL\" data-id=\"https:\/\/innere-med-1.meduniwien.ac.at\/haematology\/functional-precision-hematology-group\/\" target=\"_blank\">Prof. Dr. Philipp Staber<\/a> from the <a rel=\"noreferrer noopener\" href=\"https:\/\/www.meduniwien.ac.at\/web\/\" data-type=\"URL\" data-id=\"https:\/\/www.meduniwien.ac.at\/web\/\" target=\"_blank\">Medical University of Vienna<\/a>! <\/p>\n\n\n\n<p>In the EXALT-1 trial, Pharmacoscopy has been used to guide the treatment of patients with advanced aggressive hematological cancers. A preview of the final analysis is available <a rel=\"noreferrer noopener\" href=\"https:\/\/ash.confex.com\/ash\/2020\/webprogram\/Paper140831.html\" data-type=\"URL\" data-id=\"https:\/\/ash.confex.com\/ash\/2020\/webprogram\/Paper140831.html\" target=\"_blank\">online here<\/a>: Treatments guided by Pharmacoscopy led to <strong>improved progression free survival for 30 out of 56 patients<\/strong>! <\/p>\n\n\n\n<figure class=\"wp-block-embed-twitter wp-block-embed is-type-rich is-provider-twitter\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"twitter-tweet\" data-width=\"550\" data-dnt=\"true\"><p lang=\"en\" dir=\"ltr\">How can functional <a href=\"https:\/\/twitter.com\/hashtag\/PrecisionMedicine?src=hash&amp;ref_src=twsrc%5Etfw\">#PrecisionMedicine<\/a> drive effective treatment of late-stage blood cancer patients in the clinic? We&#39;re proud to announce that final results of the EXALT I study of <a href=\"https:\/\/twitter.com\/MedUni_Wien?ref_src=twsrc%5Etfw\">@MedUni_Wien<\/a> &amp; <a href=\"https:\/\/twitter.com\/CeMM_News?ref_src=twsrc%5Etfw\">@CeMM_News<\/a>  will be presented at <a href=\"https:\/\/twitter.com\/ASH_hematology?ref_src=twsrc%5Etfw\">@ASH_hematology<\/a> this year\u27a1\ufe0f<a href=\"https:\/\/t.co\/yLEPMS7vYK\">https:\/\/t.co\/yLEPMS7vYK<\/a> <a href=\"https:\/\/t.co\/jXCY7lkGYF\">pic.twitter.com\/jXCY7lkGYF<\/a><\/p>&mdash; CeMM (@CeMM_News) <a href=\"https:\/\/twitter.com\/CeMM_News\/status\/1328288051030863872?ref_src=twsrc%5Etfw\">November 16, 2020<\/a><\/blockquote><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script>\n<\/div><\/figure>\n\n\n\n<p><\/p>\n\n\n\n<p> <\/p>\n\n\n\n<p><a href=\"\"><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The final analysis of the succesful EXALT-1 interventional trial will be presented at the 62nd annual meeting of the American Society for Hematology by Prof. Dr. Philipp Staber from the Medical University of Vienna! In the EXALT-1 trial, Pharmacoscopy has been used to guide the treatment of patients with advanced aggressive hematological cancers. A preview&hellip; <a class=\"more-link\" href=\"https:\/\/www.snijderlab.org\/news\/2020\/11\/16\/pharmacoscopy-trial-presented-at-ash2020\/\">Continue reading <span class=\"screen-reader-text\">Pharmacoscopy trial presented at ASH2020<\/span> <span class=\"meta-nav\" aria-hidden=\"true\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,5],"tags":[],"class_list":["post-293","post","type-post","status-publish","format-standard","hentry","category-news","category-publications"],"_links":{"self":[{"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/posts\/293","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/comments?post=293"}],"version-history":[{"count":5,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/posts\/293\/revisions"}],"predecessor-version":[{"id":301,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/posts\/293\/revisions\/301"}],"wp:attachment":[{"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/media?parent=293"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/categories?post=293"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/tags?post=293"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}